Valerie K. Arnold

Associate Professor And Director

  • 2890 Citations
  • 20 h-Index
19922017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Therapeutics Medicine & Life Sciences
Attention Deficit Disorder with Hyperactivity Medicine & Life Sciences
Placebos Medicine & Life Sciences
Psychiatry Medicine & Life Sciences
Substance-Related Disorders Medicine & Life Sciences
Mental Disorders Medicine & Life Sciences
Learning Disorders Medicine & Life Sciences
Language Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

  • 2890 Citations
  • 20 h-Index
  • 19 Review article
  • 17 Article
3 Citations

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years

López, F. A., Childress, A., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R. A., Shepski, J. & Arnold, V., Jan 1 2017, In : Journal of Attention Disorders. 21, 1, p. 52-61 10 p.

Research output: Contribution to journalArticle

Placebos
Lisdexamfetamine Dimesylate
Caregivers
Parents
Incidence
1 Citations
Methylphenidate
Attention Deficit Disorder with Hyperactivity
Safety
Least-Squares Analysis
Placebos
3 Citations

Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study

Weisler, R. H., Greenbaum, M., Arnold, V., Yu, M., Yan, B., Jaffee, M. & Robertson, B., Aug 1 2017, In : CNS Drugs. 31, 8, p. 685-697 13 p.

Research output: Contribution to journalArticle

Amphetamine
Attention Deficit Disorder with Hyperactivity
Salts
Placebos
Safety
4 Citations

Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal

Mattingly, G., Culpepper, L., Babcock, T. & Arnold, V., Jan 1 2015, In : Postgraduate Medicine. 127, 3, p. 323-329 7 p.

Research output: Contribution to journalReview article

Attention Deficit Disorder with Hyperactivity
Primary Health Care
Referral and Consultation
Therapeutics
Genetic Research
12 Citations

A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

Arnold, V., Feifel, D., Earl, C. Q., Yang, R. & Adler, L. A., Feb 1 2014, In : Journal of Attention Disorders. 18, 2, p. 133-144 12 p.

Research output: Contribution to journalArticle

Placebos
Safety
Research Personnel
Therapeutics
modafinil